- Home
- SY vs HLVX Comparison
SY vs HLVX Comparison
Compare SY & HLVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SY
- HLVX
- Stock Information
- Founded
- SY 2013
- HLVX 2020
- Country
- SY China
- HLVX United States
- Employees
- SY N/A
- HLVX N/A
- Industry
- SY EDP Services
- HLVX Biotechnology: Pharmaceutical Preparations
- Sector
- SY Technology
- HLVX Health Care
- Exchange
- SY Nasdaq
- HLVX Nasdaq
- Market Cap
- SY 89.4M
- HLVX 93.1M
- IPO Year
- SY 2019
- HLVX 2022
- Fundamental
- Price
- SY $0.89
- HLVX $1.88
- Analyst Decision
- SY Hold
- HLVX Hold
- Analyst Count
- SY 1
- HLVX 5
- Target Price
- SY $0.80
- HLVX $2.33
- AVG Volume (30 Days)
- SY 36.9K
- HLVX 194.1K
- Earning Date
- SY 03-19-2025
- HLVX 03-19-2025
- Dividend Yield
- SY 6.98%
- HLVX N/A
- EPS Growth
- SY 1.45
- HLVX N/A
- EPS
- SY 0.05
- HLVX N/A
- Revenue
- SY $212,139,568.00
- HLVX N/A
- Revenue This Year
- SY $2.13
- HLVX N/A
- Revenue Next Year
- SY $4.64
- HLVX N/A
- P/E Ratio
- SY $17.48
- HLVX N/A
- Revenue Growth
- SY 3.87
- HLVX N/A
- 52 Week Low
- SY $0.66
- HLVX $1.55
- 52 Week High
- SY $1.42
- HLVX $20.22
- Technical
- Relative Strength Index (RSI)
- SY 51.77
- HLVX 43.15
- Support Level
- SY $0.81
- HLVX $1.92
- Resistance Level
- SY $0.93
- HLVX $2.00
- Average True Range (ATR)
- SY 0.06
- HLVX 0.07
- MACD
- SY -0.00
- HLVX -0.01
- Stochastic Oscillator
- SY 56.00
- HLVX 18.07
About SY So-Young International Inc. American Depository Shares
So-Young International Inc is an online destination for discovering, evaluating, and reserving medical aesthetic services in China. Its business model comprises four integrated components: professional content and its distribution through social media networks and its targeted media platforms in China, a social community characterized by signature user-generated content, Online reservation services for a medical aesthetic treatment, and the research, development, production, sales and agency of laser and other optoelectronic medical beauty equipment. It generates revenues from information services fees and reservation services fees from medical aesthetic service providers.
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.